I've written to the lead author on clarifying the placebo group to confirm they did not receive any OIT. Dr. Burks is named one of the co-authors. If anyone is heading in to see Dr. B on other business would you consider asking him what the significance of the treatment group was compared to OIT success rates with same exclusion criteria and length of treatment, please?
The central question is what is novel in comparison with rates from the standing data on OIT? What made this publishable, what is it being compared to?